Cargando…
Adjunctive Zoledronate + IL-2 administrations enhance anti-tuberculosis Vγ2Vδ2 T-effector populations, and improve treatment outcome of multidrug-resistant tuberculosis(1)
Multidrug-resistant tuberculosis (MDR-TB) is a refractory disease with high mortality rate due to no or few choices of antibiotics. Adjunctive immunotherapy may help improve treatment outcome of MDR-TB. Our decade-long studies demonstrated that phosphoantigen-specific Vγ2Vδ2 T cells play protective...
Autores principales: | Shen, Hongbo, Yang, Enzhuo, Guo, Ming, Yang, Rui, Huang, Guixian, Peng, Ying, Sha, Wei, Wang, Feifei, Shen, Ling |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9310823/ https://www.ncbi.nlm.nih.gov/pubmed/35765887 http://dx.doi.org/10.1080/22221751.2022.2095930 |
Ejemplares similares
-
Discrepancy in the transmissibility of multidrug-resistant mycobacterium tuberculosis in urban and rural areas in China
por: Li, Meng, et al.
Publicado: (2023) -
Immunization of Vγ2Vδ2 T cells programs sustained effector memory responses that control tuberculosis in nonhuman primates
por: Shen, Ling, et al.
Publicado: (2019) -
Extensive global movement of multidrug-resistant M. tuberculosis strains revealed by whole-genome analysis
por: Cohen, Keira A, et al.
Publicado: (2019) -
Secondary erythrocytosis following drugs used in rifampicin/multidrug-resistant tuberculosis: a retrospective cohort study
por: Tesfamariam, Sirak, et al.
Publicado: (2021) -
Development, assessment and validation of a novel prediction nomogram model for risk identification of tracheobronchial tuberculosis in patients with pulmonary tuberculosis
por: Qiu, Qian, et al.
Publicado: (2023)